Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma. Br J Haematol. 2017 Apr; 177(1):72-79.